| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/03/2002 | WO2002000697A2 Bonsai, a phospholipid binding protein, is required for thermal tolerance in arabidopsis |
| 01/03/2002 | WO2002000695A2 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis |
| 01/03/2002 | WO2002000694A2 Modified morbillivirus v proteins |
| 01/03/2002 | WO2002000692A2 Pd-l2 molecules: pd-1 ligands and uses therefor |
| 01/03/2002 | WO2002000691A2 Polynucleotides and polypeptides encoded thereby |
| 01/03/2002 | WO2002000690A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | WO2002000689A2 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR11, AND USES THEREOF |
| 01/03/2002 | WO2002000686A2 Bioelastomer nanomachines and biosensors |
| 01/03/2002 | WO2002000684A2 Method of obtaining peptides with tissue-specific activity and pharmaceutical compositions on their basis |
| 01/03/2002 | WO2002000617A2 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/03/2002 | WO2002000262A2 Modulation of chromosome function by chromatin remodeling agents |
| 01/03/2002 | WO2002000252A2 Non-human animal models of tolerance to hepatitis c virus immunogenes |
| 01/03/2002 | WO2002000251A1 Vaccine against foot-and-mouth disease |
| 01/03/2002 | WO2002000250A2 Hiv-1 vaccines and screening methods therefor |
| 01/03/2002 | WO2002000232A2 Methods and compositions for developing spore display systems for medicinal and industrial applications |
| 01/03/2002 | WO2002000230A1 Synthetic oxygen transport made from cross-linked modified human or porcine haemoglobin with improved properties, method for a preparation thereof from purified material and use thereof |
| 01/03/2002 | WO2002000174A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/03/2002 | WO2002000169A2 Production of vaccines using transgenic plants |
| 01/03/2002 | WO2002000024A1 New strategy for leukemia therapy |
| 01/03/2002 | WO2002000017A2 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
| 01/03/2002 | WO2002000016A1 Altered wool and hair fibres |
| 01/03/2002 | WO2002000001A2 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR20, AND USES THEREOF |
| 01/03/2002 | WO2001079429A3 A novel polypeptide - human guanine nucleotide exchange factor 10and the polynucleotide encoding said polypeptide |
| 01/03/2002 | WO2001075033A3 A novel polypeptide, a human cell division cycle regulatory protein 9 and the polynucleotide encoding the polypeptide |
| 01/03/2002 | WO2001072828A3 26649, a human gtpase activating molecule and uses therefor |
| 01/03/2002 | WO2001071005A3 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 01/03/2002 | WO2001070810A3 Atp binding cassette transporter 1 (abc1) gene polymorphisms and uses thereof for the diagnosis and treatment of lipid disorders, cardiovascular diseases and inflammatory diseases |
| 01/03/2002 | WO2001064880A3 Human dynamin 40322 |
| 01/03/2002 | WO2001059117A3 Seven-transmembrane proteins/g-protein coupled receptors |
| 01/03/2002 | WO2001058941A8 Cytokine activity regulator molecules from tick salivary glands |
| 01/03/2002 | WO2001058472A3 Botulinum toxin pharmaceutical compositions |
| 01/03/2002 | WO2001057086A3 Novel human g protein coupled receptor proteins and polynucleotides encoding the same |
| 01/03/2002 | WO2001055336A3 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/03/2002 | WO2001055317A3 Nucleic acids, proteins, and antibodies |
| 01/03/2002 | WO2001055300A3 Nucleic acids, proteins, and antibodies |
| 01/03/2002 | WO2001053344A3 Chondromodulin-i related peptide |
| 01/03/2002 | WO2001049713A3 Stabilizing peptides, polypeptides and antibodies which include them |
| 01/03/2002 | WO2001047958A3 Kunitz domain polypeptide zkun10 |
| 01/03/2002 | WO2001046696A3 Methods and compositions for detecting hepatitis e virus |
| 01/03/2002 | WO2001046421A3 Zcys5: a member of the cystatin superfamily |
| 01/03/2002 | WO2001046383A3 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 01/03/2002 | WO2001046230A3 Kunitz domain polypeptide zkun11 |
| 01/03/2002 | WO2001046219A3 Method for production of a c1 esterase inhibitor (c1-inh)-containing composition |
| 01/03/2002 | WO2001045494A3 Pyrophosphatase stress-related proteins and methods of use in plants |
| 01/03/2002 | WO2001042441A3 Plastid transformation |
| 01/03/2002 | WO2001042297A3 Clasp-3 transmembrane protein |
| 01/03/2002 | WO2001042294A3 Clasp-4 transmembrane protein |
| 01/03/2002 | WO2001040291A3 Proteins and nucleic acids encoding the same |
| 01/03/2002 | WO2001039799A3 Passive desensitization |
| 01/03/2002 | WO2001038534A3 Human serpin |
| 01/03/2002 | WO2001036632A3 Variants of alternative splicing |
| 01/03/2002 | WO2001036471A3 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 01/03/2002 | WO2001036468A3 Novel proteins having insecticidal activities and method of use |
| 01/03/2002 | WO2001036460A3 Methods and means for regulation of gene expression |
| 01/03/2002 | WO2001032883A3 Expression of the osa gene in transgenic plants confers resistance to agrobacterium transformation and crown gall disease |
| 01/03/2002 | WO2001032877A3 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 01/03/2002 | WO2001027334A3 Methods and compositions for correlating ccr5 expression with essential hypertension |
| 01/03/2002 | WO2001023553A8 Metastasis-associated antigen c4.4a |
| 01/03/2002 | WO2000059935A9 Anti-apoptotic fusion polypeptide |
| 01/03/2002 | WO2000044915A9 Method for conveying bnyvv resistance to sugar beet plants |
| 01/03/2002 | US20020002714 Transgenic plants |
| 01/03/2002 | US20020002278 Genetic engineering |
| 01/03/2002 | US20020002276 Chimeric heteromultimer adhesins |
| 01/03/2002 | US20020002272 Eliciting HCV-specific antibodies |
| 01/03/2002 | US20020002270 Purified antigen for alzheimer's disease, and methods of obtaining and using same |
| 01/03/2002 | US20020002269 Artemin, a neurotrophic factor |
| 01/03/2002 | US20020002239 Complexing with a polylactam having units derived from a heteroaromatic amino acid such as 1-methyl-2-carboxy-4-amino-pyrrole or 1-methyl-2-carboxy-4-amino-imidazole; inhibits proteins |
| 01/03/2002 | US20020002134 PAI-2 conjugates for the treatment and imaging of cancer |
| 01/03/2002 | US20020002133 Stabilized granulocyte colony stimulating factor |
| 01/03/2002 | US20020002131 Providing exogenous antiangiogenic protein to endothelial cells associated with said tissue |
| 01/03/2002 | US20020001857 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
| 01/03/2002 | US20020001843 Starch biosynthetic enzymes |
| 01/03/2002 | US20020001840 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 01/03/2002 | US20020001828 Chemokine-like factors (CKLFs) with chemotactic and hematopoietic stimulating activities |
| 01/03/2002 | US20020001827 Polypeptide for use diagnosis, prevention, and treatment of cancers, inflammation, allograft rejection, neverous system disorders and defects associated with pregnancy, propagation and development |
| 01/03/2002 | US20020001826 Hematopoietic cells and methods based thereon |
| 01/03/2002 | US20020001825 Fibroblast growth factor-like molecules and uses thereof |
| 01/03/2002 | US20020001824 Ligand-gated anion channels of insects |
| 01/03/2002 | US20020001823 Polypeptide; for use in the treatment of diabetes, obesity, atherosclerosis, inflammatory bowl disease, cancer and hypertension |
| 01/03/2002 | US20020001817 Assay for specific strains of multiple disease related conformations of a protein |
| 01/03/2002 | US20020001805 Nucleotide sequence for use in the detection, diagnosis and treatment of tumor of urogenital system |
| 01/03/2002 | US20020001625 Pharmaceutical or veterinary composition for treating wounds comprising milk product extracts including growth factors with basic to neutral isoelectric points |
| 01/03/2002 | US20020001593 Produced by inserting a foreign nucleotide sequence (from chlolera, enterotoxin, pilin, HIV protective epitope, flagellin, or cytokine) encoding an immunogenic peptide; plasmids; vaccines |
| 01/03/2002 | US20020001592 Use of Botulinum toxins for treating various disorders and conditions and associated pain |
| 01/03/2002 | CA2709771A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | CA2648051A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | CA2648048A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | CA2648046A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | CA2415761A1 Novel human gaba receptors and polynucleotides encoding the same |
| 01/03/2002 | CA2415238A1 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis |
| 01/03/2002 | CA2414396A1 Production of vaccines using transgenic plants |
| 01/03/2002 | CA2414382A1 Esr1 - a plant gene that can promote plant regeneration and transformation |
| 01/03/2002 | CA2414342A1 Materials and methods relating to the increase in protein activity |
| 01/03/2002 | CA2414308A1 Transport peptides derived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof |
| 01/03/2002 | CA2414137A1 Recombinant saccharomyces cerevisiae expressing chimeric glucose transporters |
| 01/03/2002 | CA2413800A1 Manipulation of negative stranded rna viruses by rearrangement of their genes and uses thereof |
| 01/03/2002 | CA2413793A1 Cyanobacterial nucleic acid fragments encoding proteins useful for controlling plant traits via nuclear or plastome transformation |
| 01/03/2002 | CA2413747A1 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof |
| 01/03/2002 | CA2413683A1 Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 01/03/2002 | CA2413673A1 Thymic stromal lymphopoietin receptor molecules and uses thereof |